[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576990":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":33,"centralContacts":34,"locations":40,"responsibleParty":58,"collaborators":33,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":33,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":33,"enrollmentInfo":72,"targetDuration":33,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":83,"overallStatus":87,"whyStopped":33,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Dartmouth-Hitchcock Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Lidocaine Infusion (Active)","ACTIVE_COMPARATOR","Lidocaine infusion",[13],"Drug: Lidocaine in Saline",{"label":15,"type":16,"description":17,"interventionNames":18},"Normal Saline Infusion (Sham)","SHAM_COMPARATOR","Normal saline infusion",[19],"Drug: Normal saline",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Lidocaine in Saline","Lidocaine infusion 1.5 mg\u002Fkg\u002Fhr",[9],[27],"Active",{"type":22,"name":29,"description":17,"armGroupLabels":30,"otherNames":31},"Normal saline",[15],[32],"Placebo",null,[35],{"name":36,"role":37,"phone":38,"phoneExt":33,"email":39},"Lauren K Buhl, MD, PhD","CONTACT","603-650-5922","lauren.k.buhl@hitchcock.org",[41],{"facility":42,"status":33,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Dartmouth Hitchcock Medical Center","Lebanon","New Hampshire","03766","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-72.25176,43.64229,{"lat":52,"lon":51},[55],{"name":56,"role":37,"phone":57,"phoneExt":33,"email":39},"Lauren Buhl, MD, PhD","603-650-5000",{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"PRINCIPAL_INVESTIGATOR","Lauren K. Buhl","Principal Investigator","100576990","phase-4-influence-of-lidocaine-infusion-on-motor-evoked-potential-thresholds-100576990",false,"NCT06792474","Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds","Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds; a Single-center, Double-blinded, Randomized Trial for Patients Undergoing Spin Surgery With Intraoperative Neurophysiologic Monitoring.","Inclusion Criteria:\n\n* Patients undergoing elective cervical or thoracolumbar spine surgery with intraoperative neurophysiological monitoring\n\nExclusion Criteria:\n\n* Inability to provide informed consent in English\n* Pregnancy (based on patient report or a positive test on the day of surgery)\n* Contraindication to lidocaine\n* Planned post-operative intubation\n* Current incarceration",true,"ALL","18 Years",{"count":73,"type":74},44,"ESTIMATED","INTERVENTIONAL",[77],"PHASE4","The purpose of this study is to determine the effect of lidocaine infusion on intraoperative neuromonitoring in patients undergoing spine surgery.",[80,81,82],"Spinal Disease","Anesthesia","Post Operative Pain",[84,85,86,82],"Lidocaine","Intraoperative Neuromonitoring","Spine surgery","NOT_YET_RECRUITING","2025-11-19",{"date":90,"type":91},"2025-11-24","ACTUAL",{"date":93,"type":74},"2026-08",{"date":95,"type":74},"2027-08",{"name":5,"class":6},1]